COVID-19: Licensing agreement for new candidate drug ‘an important first step’

Access to a new COVID-19 drug will be expanded in low- and middle-income countries following a voluntary licensing agreement between the pharmaceutical company Pfizer and a UN-backed global health initiative, announced in Geneva on Tuesday.

Read the full story, “COVID-19: Licensing agreement for new candidate drug ‘an important first step’”, on globalissues.org →

from Global Issues News Headlines https://ift.tt/3wQe2t0
via IFTTT